Medico

Specialista in Dermatologia e venereologia

giuseppecianchini@gmail.com

UOC Patologia clinica e malattie autoimmuni e infiammatorie della cute. Ospedale Cristo RE Via delle Calasanziane 59, Roma

Speaker all’ International Meeting on Autoimmune bullous diseases, National Institute of Health, Bethesda, Maryland, US nov,5-6  2010, con una lettura su ‘Rituximab is a safe and effective treatment for pemphigus: results from a sigle center trial on 54 cases’.

Chairman and Speaker al 22° World Congress of Dermatology of Seoul (South Korea), may, 24-29 2011 in workshop ‘Complications of iatrogenic immunosuppression’ con una relazione su  ‘Immuno suppressive agents and their side effects in bullous autoimmune disorders’.

Speaker al 22° World Congress of Dermatology of Seoul (South Korea), may, 24-29 2011 in workshop ‘Autoimmune bullous disease: new treatments’ con una relazione su  ‘Emerging B cell depletion strategies’.

Speaker al 9th Spring Congress of the European Academy of Dermatology and Venereology, Verona, june 6-10 2012, con una lettura su ‘B cell depletion strategies in autoimmune bullous diseases’.

Chairman and Speaker al 23th Congress of the European Academy of Dermatology and Venereology, Praga, Czech Republic, sept 27-30, 2012, in  workshop ‘Which biologics for which indications’, con una lettura su  ‘B cell depletion for autoimmune bullous diseases: indications and use’.

Chairman all’international Meeting on Autoimmune bullous diseases, Lubeck, Germany, may 6-7, 2013, in workshop ‘Outcome measures and novel treatments’.

Speaker all’international IPPF meeting on autoimmune bullous diseases, Lubeck, Germany,  22-23 june 2017 con una lettura su ‘B cell depletion therapy for a long term control of mucous membrane pemphigoid’

Speaker al 24° World Congress of Dermatology of Milano (Italy), june, 10-15 2019 in workshop ‘ADOI: clinical research in the hospital setting‘ con una relazione su ‘Autoimmune blistering diseases: new therapeutic options’

Attualmente lavora come Dirigente dermatologo presso Unità Operativa Complessa di Patologia clinica e malattie autoimmuni e infiammatorie della cute dell’ospedale Cristo Re in Roma.